稳健医疗
(300888)
| 流通市值：174.40亿 | | | 总市值：175.18亿 |
| 流通股本：5.80亿 | | | 总股本：5.83亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,195,922,771.75 | 5,486,211,258.52 | 2,679,328,547.73 | 10,949,489,967.01 |
| 营业收入 | 8,195,922,771.75 | 5,486,211,258.52 | 2,679,328,547.73 | 10,949,489,967.01 |
| 二、营业总成本 | 7,313,823,427.55 | 4,860,235,265.17 | 2,345,297,815.47 | 9,733,808,334.16 |
| 营业成本 | 4,256,321,556.18 | 2,798,167,916.13 | 1,368,538,882.04 | 5,733,463,029.53 |
| 税金及附加 | 76,702,554.88 | 54,141,091.23 | 24,985,906.96 | 93,698,779.57 |
| 销售费用 | 1,953,498,110.26 | 1,319,852,862.34 | 611,332,276.63 | 2,633,668,842.91 |
| 管理费用 | 636,347,620.22 | 429,235,127.33 | 214,383,181.15 | 855,447,401.69 |
| 研发费用 | 302,884,752.72 | 192,440,074.86 | 91,133,594.78 | 410,877,566.24 |
| 财务费用 | 88,068,833.29 | 66,398,193.28 | 34,923,973.91 | 6,652,714.22 |
| 其中:利息费用 | 34,495,694.85 | 25,093,014.26 | 12,506,380.19 | 55,114,093.69 |
| 其中:利息收入 | 50,793,849.88 | 37,540,602.03 | 21,062,129.49 | 82,400,032.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 9,448,350.57 | 31,032,052.63 | 12,132,519.08 | -24,339,525.82 |
| 加:投资收益 | 26,993,468.85 | 9,965,393.41 | 972,472.41 | 53,091,575.78 |
| 资产处置收益 | -85,390.1 | -478,162.3 | -736,515.7 | 546,546.56 |
| 资产减值损失(新) | -37,632,359.07 | -37,175,924.45 | -18,645,697.75 | -251,273,437.71 |
| 信用减值损失(新) | -8,521,503.71 | -7,345,527.12 | 2,850,979.41 | -10,273,088.79 |
| 其他收益 | 47,619,925.72 | 43,044,484.26 | 22,028,266.16 | 84,244,396.64 |
| 四、营业利润 | 919,921,836.46 | 665,018,309.78 | 352,632,755.87 | 1,067,678,099.51 |
| 加:营业外收入 | 8,173,426.92 | 4,037,383.38 | 2,318,960.53 | 8,206,430.16 |
| 减:营业外支出 | 9,235,860.2 | 6,688,151.1 | 6,783,888.69 | 28,063,679.49 |
| 五、利润总额 | 918,859,403.18 | 662,367,542.06 | 348,167,827.71 | 1,047,820,850.18 |
| 减:所得税费用 | 134,283,617.11 | 117,100,459.42 | 77,409,979.74 | 233,703,122.41 |
| 六、净利润 | 784,575,786.07 | 545,267,082.64 | 270,757,847.97 | 814,117,727.77 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 784,575,786.07 | 545,267,082.64 | 270,757,847.97 | 814,117,727.77 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 740,888,425.83 | 513,499,129.9 | 251,490,441.26 | 767,967,461.87 |
| 少数股东损益 | 43,687,360.24 | 31,767,952.74 | 19,267,406.71 | 46,150,265.9 |
| 扣除非经常损益后的净利润 | 696,183,771.18 | 462,326,436.7 | 227,031,917.38 | 705,635,870.36 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.28 | 0.88 | 0.43 | 1.32 |
| (二)稀释每股收益 | 1.28 | 0.88 | 0.43 | 1.32 |
| 八、其他综合收益 | -39,378,974.64 | -22,542,370.04 | -16,596,636.92 | -1,581,626.72 |
| 归属于母公司股东的其他综合收益 | -37,637,907.17 | -24,342,713.77 | -15,819,826.9 | -9,197,211.89 |
| 九、综合收益总额 | 745,196,811.43 | 522,724,712.6 | 254,161,211.05 | 812,536,101.05 |
| 归属于母公司股东的综合收益总额 | 703,250,518.66 | 489,156,416.13 | 235,670,614.36 | 758,770,249.98 |
| 归属于少数股东的综合收益总额 | 41,946,292.77 | 33,568,296.47 | 18,490,596.69 | 53,765,851.07 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-22 | 2026-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |